Is Vitamin B12 (Cyanocobalamin) Safe with Wegovy?
Free · No account · based on published sources including NIH ODS, FDA drug labels, and peer-reviewed literature
Given higher doses used for obesity management, routine B12 monitoring is strongly recommended every 6 months. Use sublingual or injectable B12 forms. Report symptoms of deficiency (tingling, fatigue, memory issues) to your provider promptly.
Why this interaction occurs
Wegovy uses higher semaglutide doses (up to 2.4mg weekly) leading to more pronounced gastric motility reduction and significant caloric restriction. This combination substantially reduces dietary B12 intake and impairs the absorption mechanism. Bariatric-level B12 deficiency risk is a clinical concern with long-term high-dose GLP-1 therapy.
Evidence
Evidence level: moderate.
Reported safety data
The FDA’s adverse event reporting system (FAERS) has received 21,044 reports mentioning Wegovy. This reflects reported cases involving the medication in general — not confirmed causation, and not specific to the Wegovy + supplement combination on this page.
FAERS reports are voluntary and cannot prove that a drug caused an event. Do not use report counts to assess the safety of this specific drug-supplement pair.
Frequently asked questions
Related interactions
All Vitamin B12 (Cyanocobalamin) interactions → · All Wegovy interactions →
Already checked this one — check your whole list
Educational only — not medical advice.
Always confirm with your doctor or pharmacist.